(Q48730129)

15 February 2018

title

Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation? (English)

1 reference

15 February 2018

3

Kutluk Oktay

1 reference

15 February 2018

author name string

Norbert Gleicher

series ordinal

1

1 reference

15 February 2018

Andrea Weghofer

series ordinal

2

1 reference

15 February 2018

David H Barad

series ordinal

4

1 reference

15 February 2018

publication date

30 December 2008

1 reference

15 February 2018

published in

Reproductive Sciences

1 reference

15 February 2018

volume

16

1 reference

15 February 2018

issue

5

1 reference

15 February 2018

page(s)

462-467

1 reference

15 February 2018

The FMR1 premutation and reproduction

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Reproductive and menstrual history of females with fragile X expansions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Evidence of early ovarian aging in fragile X premutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Early ovarian ageing: a hypothesis. Detection and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

ACOG committee opinion. No. 338: Screening for fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

What should be the maximum FSH dose in IVF/ICSI in poor responders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Is there a recommended maximum starting dose of FSH in IVF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Increased oocyte production after treatment with dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

Subfertility reflects accelerated ovarian ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719108328617

21 January 2018

Identifiers

DOI

10.1177/1933719108328617

1 reference

15 February 2018

1 reference

15 February 2018